Labour productivity losses caused by premature death associated with hepatitis C in Spain.

Abstract:

BACKGROUND AND AIMS:Hepatitis C virus (HCV) infection places a huge burden on healthcare systems. There is no study assessing the impact of HCV infection on premature deaths in Spain. The aim of this study was to estimate productivity losses because of premature deaths attributable to hepatitis C occurring in Spain during 2007-2011. MATERIALS AND METHODS:We use data from several sources (Registry of Deaths, Labour Force Survey and Wage Structure Survey) to develop a simulation model based on the human capital approach and to estimate the flows in labour productivity losses in the period considered. The attributable fraction method was used to estimate the numbers of deaths associated with HCV infection. Two sensitivity analyses were developed to test the robustness of the results. RESULTS:Our model shows total productivity losses attributable to HCV infection of 1054.7 million euros over the period analysed. The trend in productivity losses is decreasing over the period. This result is because of improvements in health outcomes, reflected in the reduction of the number of years of potential productive life lost. Of the total estimated losses, 18.6% were because of hepatitis C, 24.6% because of hepatocellular carcinoma, 30.1% because of cirrhosis, 15.9% because of other liver diseases and 10.7% because of HIV-HCV coinfection. CONCLUSION:The results show that premature mortality attributable to hepatitis C involves significant productivity losses. This highlights the need to extend the analysis to consider other social costs and obtain a more complete picture of the actual economic impact of hepatitis C infection.

authors

Oliva-Moreno J,Peña-Longobardo LM,Alonso S,Fernández-Bolaños A,Gutiérrez ML,Hidalgo-Vega Á,de la Fuente E,Fernández-Rodríguez CM

doi

10.1097/MEG.0000000000000336

subject

Has Abstract

pub_date

2015-06-01 00:00:00

pages

631-7

issue

6

eissn

0954-691X

issn

1473-5687

journal_volume

27

pub_type

杂志文章
  • Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.

    abstract:OBJECTIVE:An inappropriate mucosal immune response to the commensal bacterial flora may play a role in the pathogenesis of inflammatory bowel disease (IBD). In this study we determined the percentage of immunoglobulin-coated bacteria in the stools of patients and controls. METHODS:Faecal samples were obtained from 18 ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/01.meg.0000108346.41221.19

    authors: van der Waaij LA,Kroese FG,Visser A,Nelis GF,Westerveld BD,Jansen PL,Hunter JO

    更新日期:2004-07-01 00:00:00

  • Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.

    abstract::The introduction of expandable metal stents in the mid 1980s led to the development of transjugular intrahepatic portosystemic stent-shunt (TIPSS) as we know it today. Short-lived detrimental effects on the hyperdynamic circulation in cirrhosis accompany the acute reduction in portal pressure following TIPSS creation....

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,评审

    doi:10.1097/01.meg.0000236871.78280.a7

    authors: Tripathi D,Redhead D

    更新日期:2006-11-01 00:00:00

  • Faecal calprotectin: a marker of inflammation throughout the intestinal tract.

    abstract::Only a small proportion of patients with abdominal discomfort have organic disease, but a correct diagnosis can seldom be made by simple clinical examination. Additional diagnostic procedures must be employed, but these are expensive and demanding and carry a certain risk. Assessment of faecal concentrations of the ne...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 评论,社论

    doi:10.1097/00042737-200208000-00002

    authors: Aadland E,Fagerhol MK

    更新日期:2002-08-01 00:00:00

  • Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?

    abstract:BACKGROUND:Adalimumab (ADA) is a subcutaneous anti-tumour necrosis factor (anti-TNF) agent, effective in inducing and maintaining remission in Crohn's disease (CD). Unlike Infliximab (IFX), ADA dosing is not weight adjusted and dose frequency is based on clinical response. AIM:To determine whether obesity is a risk fa...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e32835d1f15

    authors: Bhalme M,Sharma A,Keld R,Willert R,Campbell S

    更新日期:2013-05-01 00:00:00

  • Endoscopically assisted percutaneous transesophageal gastrotubing: a retrospective pilot study.

    abstract:BACKGROUND:Percutaneous transesophageal gastrotubing (PTEG) was developed as an alternative route to access the gastrointestinal tract when percutaneous endoscopic gastrostomy is contraindicated. PTEG was originally performed without endoscopy. However, endoscopy may enhance safety. MATERIALS AND METHODS:A percutaneou...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e3283614ae1

    authors: Murakami M,Nishino K,Takaoka Y,Murakami S,Mori K,Murakami B,Azuma M,Tanabe S,Kida M,Koizumi W

    更新日期:2013-08-01 00:00:00

  • Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.

    abstract:BACKGROUND AND AIMS:Left ventricular diastolic dysfunction has been reported in patients with liver cirrhosis. Although conventional Doppler echocardiography has been used to assess diastolic filling dynamics, this technique is limited in diagnosing left ventricular diastolic dysfunction. The aim of the study was to va...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e3282fb7cd0

    authors: Raedle-Hurst TM,Welsch C,Forestier N,Kronenberger B,Hess G,Herrmann E,Zeuzem S,Raedle J

    更新日期:2008-09-01 00:00:00

  • The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study.

    abstract:OBJECTIVES:In 30% of patients with primary biliary cirrhosis (PBC) ursodeoxycholic acid (UDCA) causes full biochemical normalization, while 70% are incomplete responders. The only differences between the two groups are the significantly higher cholestasis indices in the incomplete responders. In these patients we inves...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200212000-00014

    authors: Leuschner M,Holtmeier J,Ackermann H,Leuschner U

    更新日期:2002-12-01 00:00:00

  • Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study.

    abstract:OBJECTIVES:Spontaneous bacterial peritonitis (SBP) is a prevalent and high mortality complication of cirrhosis. We aimed to describe these patients' clinical and microbiological characteristics and evaluate their impact on outcomes. METHODS:This was a retrospective cohort study including 139 consecutive patients with ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000700

    authors: Oliveira AM,Branco JC,Barosa R,Rodrigues JA,Ramos L,Martins A,Karvellas CJ,Cardoso FS

    更新日期:2016-10-01 00:00:00

  • Inadequate use of proton-pump inhibitors in patients with liver cirrhosis.

    abstract:OBJECTIVES:Patients with liver cirrhosis have a high prevalence of gastrointestinal symptoms. The use of antiacid therapy (AAT) in these patients is unexplored. We aimed to assess the use of AAT in cirrhotic patients. METHODS:A total of 128 consecutive cirrhotic patients were evaluated for the use of and indications f...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e3282f4aa01

    authors: Kalaitzakis E,Björnsson E

    更新日期:2008-06-01 00:00:00

  • Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication.

    abstract:BACKGROUND AND AIM:Antibiotic-associated diarrhoea may develop during or following Helicobacter pylori eradication. We aimed to evaluate the efficacy and safety of Saccharomyces boulardii in preventing antibiotic-associated diarrhoea in patients receiving antibiotics for H. pylori eradication. METHODS:In a multicentre...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1097/00042737-200512000-00015

    authors: Duman DG,Bor S,Ozütemiz O,Sahin T,Oğuz D,Iştan F,Vural T,Sandkci M,Işksal F,Simşek I,Soytürk M,Arslan S,Sivri B,Soykan I,Temizkan A,Beşşk F,Kaymakoğlu S,Kalayc C

    更新日期:2005-12-01 00:00:00

  • Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease.

    abstract:OBJECTIVE:Ileocaecal resection is the most common operation performed in Crohn's disease. Our study aimed to identify the risk factors for anastomotic recurrence following primary ileocaecal resection. PATIENTS AND METHODS:We retrospectively analysed data from all Crohn's disease surgical patients in a single colorect...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000001206

    authors: Aaltonen G,Keränen I,Carpelan-Holmström M,Lepistö A

    更新日期:2018-10-01 00:00:00

  • Unusual manifestation of brucellosis: liver abscess and pancytopenia caused by Brucella melitensis.

    abstract::Brucellosis is a zoonosis with a worldwide distribution, and still endemic in Greece. Although hepatic involvement is common, cholecystitis and hepatic abscesses represent rare complications of the disease. Hematological manifestations of brucellosis include various abnormalities such as anemia and leucopenia, but the...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e3282ef9493

    authors: Starakis I,Polyzogopoulou E,Siagris D,Mazokopakis E,Gogos CA

    更新日期:2008-04-01 00:00:00

  • Atrophy, acid suppression and Helicobacter pylori infection: a tale of two studies.

    abstract::Much of what is currently accepted regarding Helicobacter pylori-associated gastritis and its relationship with gastric adenocarcinoma rests on the assumption that atrophic gastritis can be correctly identified and reproducibly recognized. Several studies have indicated that pathologists have a low level of agreement ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199908002-00006

    authors: Genta RM

    更新日期:1999-08-01 00:00:00

  • Histological changes in the gastric mucosa after Helicobacter pylori eradication.

    abstract:BACKGROUND AND AIM:Correa described a stepwise model of changes in the gastric mucosa after Helicobacter pylori infection, from the normal gastric epithelium to chronic gastritis, atrophy, intestinal metaplasia, dysplasia and adenocarcinoma. The aim of this study is to assess the reversibility of these mucosal changes ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200411000-00017

    authors: Fichman S,Niv Y

    更新日期:2004-11-01 00:00:00

  • Molecular and immunohistochemical profile of a basaloid (cloacogenic) carcinoma of the sigmoid colon: possible predictive value for clinical outcomes.

    abstract::A 61-year-old woman was hospitalized with a 5-week history of abdominal discomfort, change in bowel habits, and weight loss. Colonoscopy showed a protruded tumor of the sigmoid colon first diagnosed as undifferentiated carcinoma. Surgical resection of the sigmoid colon was performed. Histological examination of the su...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000064

    authors: Gurzu S,Szentirmay Z,Bara T,Bara T Jr,Iurcsuk O,Jung I

    更新日期:2014-05-01 00:00:00

  • Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group.

    abstract:OBJECTIVE:To investigate a possible dose-effect relationship with two dosages of oral slow-release mesalazine in patients with quiescent ulcerative colitis. METHOD:One hundred and sixty-nine patients with ulcerative colitis in remission were treated with either 1.5 or 3.0 g/day mesalazine for 1 year or until relapse i...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1097/00042737-199511000-00003

    authors: Fockens P,Mulder CJ,Tytgat GN,Blok P,Ferwerda J,Meuwissen SG,Tuynman HA,Dekker W,Gasthuis K,van Hees PA

    更新日期:1995-11-01 00:00:00

  • Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?

    abstract:OBJECTIVES:To examine the relationship between serum levels of anti-Saccharomyces cerevisiae antibodies (ASCAs) and intestinal permeability at a given time (hypothesis 1) and the probability of increased ASCA serum levels with increased intestinal permeability (hypothesis 2) in patients with Crohn's disease. METHODS:E...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200312000-00005

    authors: Harrer M,Reinisch W,Dejaco C,Kratzer V,Gmeiner M,Miehsler W,Norman GL,Gangl A,Vogelsang H

    更新日期:2003-12-01 00:00:00

  • Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

    abstract:OBJECTIVE:Recent studies have suggested that endotoxin-induced cytokines play an important role in nonalcoholic fatty liver disease (NAFLD). Rifaximin is a nonabsorbable antibiotic that might act on Gram-negative bacteria, thereby inhibiting endotoxin proinflammatory cytokine production in patients with NAFLD. Our aim ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000348

    authors: Gangarapu V,Ince AT,Baysal B,Kayar Y,Kılıç U,Gök Ö,Uysal Ö,Şenturk H

    更新日期:2015-07-01 00:00:00

  • Serum anti-Lewis X antibody is associated with VacA seropositivity but not atrophic gastritis in patients with Helicobacter pylori infection.

    abstract:OBJECTIVES:Lipopolysaccharides of Helicobacter pylori have an antigenic structure that mimics Lewis X occurring in gastric mucosa. The pathogenic role of antigenic mimicry in H. pylori-induced gastritis has been of recent interest. The aim of this study was to examine the relevance of anti-Lewis X antibody in the devel...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200103000-00002

    authors: Shimoyama T,Fukuda S,Tanaka M,Sugawara N,Kurimoto F,Munakata A

    更新日期:2001-03-01 00:00:00

  • Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?

    abstract::Gilbert's syndrome is a common inherited disorder, in which genetic defects in uridine diphosphate-glucuronosyltransferase 1A1 lead to deficient glucuronidation of bilirubin and hence hyperbilirubinaemia. Although usually considered asymptomatic, Gilbert's syndrome can be associated with gastrointestinal and psychiatr...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e328012b431

    authors: Lee P,Jones G,Seibel MJ

    更新日期:2007-04-01 00:00:00

  • Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations.

    abstract:BACKGROUND:Massive amounts of patient data are captured daily in electronic medical records (EMR). Utilizing the power of such large data may help identify disease associations and generate hypotheses that can lead to a better understanding of disease associations and mechanisms. We aimed to comprehensively identify an...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000001869

    authors: Waljee AK,Noureldin M,Berinstein JA,Cohen-Mekelburg SA,Wallace BI,Cushing KC,Hanauer DA,Keeney-Bonthrone TP,Nallamothu B,Higgins PDR

    更新日期:2020-10-01 00:00:00

  • Colonic endocrine cells in patients with carcinoma of the colon.

    abstract:OBJECTIVE:To investigate the colonic endocrine cells in patients with colon carcinoma in order to establish a possible abnormality. PATIENTS:Twelve patients with colon adenocarcinoma (eight women and four men; mean age 69 years; range 52-88 years) were studied. As controls, macroscopically and histologically normal ti...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199806000-00015

    authors: El-Salhy M,Mahdavi J,Norrgård O

    更新日期:1998-06-01 00:00:00

  • Treatment of hepatitis B virus infection in chronic infection with HBeAg-positive adult patients (immunotolerant patients): a systematic review.

    abstract::Recently, a controversial approach suggesting the early treatment of chronic infection with hepatitis B "e" antigen-positive patients with hepatitis B virus (HBV) infection, has been proposed. The objective of this study is to systematically review medical literature regarding treatment of HBV infection in adult chron...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000001907

    authors: Tovo CV,Ahlert M,Panke C,de Mattos ÂZ,de Mattos AA

    更新日期:2020-09-15 00:00:00

  • Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori--a randomized, double-blind comparison of a three times daily and twice daily regimen.

    abstract:OBJECTIVES:To determine the efficacy of a three times daily (t.i.d.) versus a twice daily (b.i.d.) regimen of combination amoxycillin and metronidazole and famotidine in the eradication of Helicobacter pylori and the influence of metronidazole resistance on the outcome of treatment. PATIENTS:Patients selected had uneq...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00042737-199711000-00012

    authors: Goh KL,Parasakthi N,Chuah SY,Toetsch M

    更新日期:1997-11-01 00:00:00

  • Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.

    abstract:OBJECTIVES:Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) are highly prevalent in the general population, with significant symptom overlap, whereas the interaction between both remains poorly understood. We aim to identify the clinical and psychological factors that contribute toward the over...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000334

    authors: Hsu CS,Liu TT,Wen SH,Wang CC,Yi CH,Chen JH,Lei WY,Orr WC,Fabio P,Chen CL

    更新日期:2015-05-01 00:00:00

  • The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia.

    abstract:OBJECTIVE:There is currently no reliable tool for providing a global measurement of the severity of dyspepsia in patients with a variety of upper gastrointestinal disorders. We have designed a questionnaire which records frequency of symptoms, effect on routine activities, time off work, frequency of medical consultati...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199610000-00006

    authors: el-Omar EM,Banerjee S,Wirz A,McColl KE

    更新日期:1996-10-01 00:00:00

  • Implementation of a guideline versus use of individual prognostic factors to prioritize waiting lists for upper gastrointestinal endoscopy.

    abstract:BACKGROUND:Studying factors associated with positive gastroscopies in dyspeptic patients can help limit and rationalize waiting lists for endoscopies. Dyspepsia guidelines have a controversial role because their main purpose is to provide specifications on efficient global management of primary care patients. AIM:To a...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/01.meg.0000216942.42306.d5

    authors: Cardin F,Zorzi M,Terranova O

    更新日期:2007-07-01 00:00:00

  • Gastric ulcers and Helicobacter heilmannii.

    abstract:OBJECTIVE:To compare 14 patients with gastric ulcer and Helicobacter heilmannii with other patients with gastric ulcer: age and sex matched patients, patients colonized by Helicobacter pylori and patients on nonsteroidal anti-inflammatory drugs (NSAIDs). SETTING:The endoscopy unit of a university-affiliated hospital. ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199803000-00011

    authors: Debongnie JC,Donnay M,Mairesse J,Lamy V,Dekoninck X,Ramdani B

    更新日期:1998-03-01 00:00:00

  • No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.

    abstract:OBJECTIVE:To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS:The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used to enroll ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000703

    authors: Hung TH,Tsai CC,Tseng CW,Tseng KC,Hsieh YH,Tsai CC

    更新日期:2016-11-01 00:00:00

  • Trends in incidence of oesophageal and stomach cancer subtypes in Europe.

    abstract:OBJECTIVE:Time trend studies in the USA have shown that the incidences of adenocarcinomas of the oesophagus and gastric cardia have risen strongly since the 1970s, whereas the incidence of squamous cell carcinomas of the oesophagus has declined. Earlier, we found that the incidence of these adenocarcinomas also rose in...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e32832ca091

    authors: Steevens J,Botterweck AA,Dirx MJ,van den Brandt PA,Schouten LJ

    更新日期:2010-06-01 00:00:00